Coastline Trust Co lessened its stake in Monsanto (NYSE:MON) by 44.8% in the fourth quarter, Holdings Channel reports. The fund owned 2,649 shares of the basic materials company’s stock after selling 2,150 shares during the period. Coastline Trust Co’s holdings in Monsanto were worth $309,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Creative Planning lifted its stake in shares of Monsanto by 4.2% in the 4th quarter. Creative Planning now owns 26,559 shares of the basic materials company’s stock valued at $3,102,000 after acquiring an additional 1,061 shares during the last quarter. Gateway Investment Advisers LLC lifted its stake in shares of Monsanto by 18.2% in the 4th quarter. Gateway Investment Advisers LLC now owns 367,741 shares of the basic materials company’s stock valued at $42,945,000 after acquiring an additional 56,734 shares during the last quarter. Bank of Montreal Can lifted its stake in shares of Monsanto by 75.1% in the 4th quarter. Bank of Montreal Can now owns 1,043,409 shares of the basic materials company’s stock valued at $121,850,000 after acquiring an additional 447,662 shares during the last quarter. Factory Mutual Insurance Co. lifted its stake in shares of Monsanto by 6.4% in the 4th quarter. Factory Mutual Insurance Co. now owns 665,900 shares of the basic materials company’s stock valued at $77,765,000 after acquiring an additional 40,000 shares during the last quarter. Finally, DnB Asset Management AS lifted its stake in shares of Monsanto by 2.9% in the 4th quarter. DnB Asset Management AS now owns 93,057 shares of the basic materials company’s stock valued at $10,867,000 after acquiring an additional 2,600 shares during the last quarter. 75.37% of the stock is owned by institutional investors.

In other Monsanto news, EVP Steven Mizell sold 8,100 shares of the company’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $119.35, for a total transaction of $966,735.00. Following the transaction, the executive vice president now owns 56,743 shares in the company, valued at approximately $6,772,277.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.79% of the company’s stock.

Monsanto (NYSE:MON) opened at $118.86 on Friday. The company has a market capitalization of $52,320.00, a P/E ratio of 21.97, a price-to-earnings-growth ratio of 1.71 and a beta of 1.04. The company has a current ratio of 1.28, a quick ratio of 0.79 and a debt-to-equity ratio of 1.05. Monsanto has a 52-week low of $106.97 and a 52-week high of $122.79.

Monsanto (NYSE:MON) last released its quarterly earnings results on Thursday, January 4th. The basic materials company reported $0.41 EPS for the quarter, missing analysts’ consensus estimates of $0.42 by ($0.01). The business had revenue of $2.66 billion for the quarter, compared to the consensus estimate of $2.77 billion. Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The company’s revenue for the quarter was up .3% on a year-over-year basis. During the same period in the previous year, the company earned $0.21 EPS. equities research analysts forecast that Monsanto will post 5.76 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be given a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date of this dividend is Thursday, January 4th. Monsanto’s payout ratio is 39.93%.

A number of equities research analysts have recently weighed in on MON shares. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. BMO Capital Markets reissued a “buy” rating and issued a $128.00 target price on shares of Monsanto in a research note on Thursday, October 5th. Barclays reissued an “equal weight” rating and issued a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Macquarie lowered Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Finally, Deutsche Bank reaffirmed a “buy” rating on shares of Monsanto in a research report on Tuesday. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Monsanto has an average rating of “Hold” and an average price target of $127.30.

TRADEMARK VIOLATION NOTICE: This piece of content was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/01/19/coastline-trust-co-sells-2150-shares-of-monsanto-mon.html.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related stocks with our FREE daily email newsletter.